Can this week’s big fallers bounce back? Circassia Pharmaceuticals plc (-59%), Stadium Group plc (-27%) & Photo-Me International plc (-11%)

Are Circassia Pharmaceuticals plc (LON:CIR), Stadium Group plc (LON:SDM) and Photo-Me International plc (LON:PHTM) falling knives or bargain buys?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

Risky & expensive

Shares in Neil Woodford-backed Circassia Pharmaceuticals (LSE: CIR) fell by almost 60% in one day this week, after the firm said its cat allergy treatment had failed a key trial.

In the firm’s latest study, its cat allergy immunotherapy treatment was found to reduce allergy symptoms by almost 60%. The problem is that patients who received a placebo instead saw an almost identical reduction in their symptoms. In my view, this suggests that many patients’ allergies are psychosomatic, rather than physical. The potential market for this product could be limited.

You may not agree with my conclusions, but what is clear is that Circassia shares were priced for a big success. Circassia’s market cap — after this week’s 60% drop — is still £300m. Although the firm currently has net cash of £136m, this is down from £203m at the end of last year.

Circassia appears to be burning through cash quite quickly. The firm is expected to report a loss of £68m this year. As cash continues to fall, I expect the share price to follow.

In my opinion, Circassia is both risky and expensive. I wouldn’t bet on a rebound.

Customer loss will hit results

As I write, today’s biggest faller is small cap electronics firm Stadium Group (LSE: SDM), which is down 27%.

The firm’s shares fell sharply when markets opened this morning, after Stadium said that its wireless division had lost a major customer. Stadium also said that sales in the group’s electronic manufacturing services division were falling faster than expected. This part of the business is being wound down as Stadium shifts its focus to design work.

As a result of the customer loss, Stadium now expects its full-year results to be below market expectations.

Broker forecasts were suggesting that Stadium would report earnings of 10.9p per share this year. I suspect these forecasts will be cut by at least 10% after today, suggesting a figure of about 9.8p. With the shares now trading at 78p, I estimate Stadium has a 2016 forecast P/E of 8.

Debt levels are low and if last year’s 2.7p dividend is maintained, Stadium could offer a dividend yield of 3.5%. There’s definite turnaround potential here, but I’d be cautious about investing until Stadium shows stronger signs of growth.

Quality, but too pricey?

Photo booth operator Photo-Me International (LSE: PHTM) slumped on Tuesday after the firm said that the timing of the next stage of a major ID card project in Japan was uncertain.

This overshadowed a record set of results for the firm, which reported record pre-tax profits of £40.1m and a 20% dividend increase to 5.86p per share. Photo-Me also announced a special dividend of 2.815p per share, which will be paid out of the group’s £62m net cash balance.

My view is that Photo-Me is a quality business, despite this week’s falls. The firm maintained its 21.5% operating margin last year and offers an ordinary dividend yield of 4.3%. My only reservation is that the outlook for earnings growth looks a bit uncertain.

On that basis, the stock looks quite fully valued, with a forecast P/E of about 16. I think there’s probably better value elsewhere.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

Under £14 now, Persimmon’s share price is trading at less than half its fair value by my reckoning

Persimmon’s share price fell a lot over the past year, but I think a new home-building initiative and improved macroeconomic…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Is this FTSE 100 pharma gem now a brilliant bargain?

This FTSE 100 pharmaceutical giant has been hit by fears of US tariffs and litigation over a key product, but…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Is Warren Buffett losing his touch?

Our writer's noticed that Warren Buffett’s investment vehicle has underperformed the S&P 500 during three of the past four years.…

Read more »

Investing Articles

Non-energy minerals are the top performers in 2025. These small-cap FTSE shares are leading the charge

Mark Hartley examines which sectors are doing well in 2025 and the FTSE shares that investors should consider to benefit…

Read more »

Emma Raducanu for Vodafone billboard animation at Piccadilly Circus, London
Investing Articles

Buying 10,000 Vodafone shares generates a passive income of…

Vodafone shares have had a rough ride, with dividends slashed in half. But with its turnaround making steady progress, is…

Read more »

Businesswoman calculating finances in an office
Investing Articles

Buying 1,000 Aviva shares generates an income of…

Aviva shares could be primed to thrive in the long run if its takeover of Direct Line is a success,…

Read more »

Investing Articles

At today’s price, buying 1,000 British American Tobacco shares generates a second income of…

Tobacco companies may not be popular, but the British American Tobacco share price is on the rise, along with its…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

The cheapest UK stock in my ISA is…

This UK stock currently trades at a massive discount to the market. Edward Sheldon believes it's mispriced and that there's…

Read more »